Analysis: Fermenta Biotech Ltd.

BSE:FERMENTA Pharma - API Market cap: ₹1.5K cr

Research report

companyname: Fermenta Biotech Limited ticker: FERMENTA sector: Pharmaceuticals / Specialty vitamins and nutraceutical ingredients (biotechnology) Fermenta Biotech Limited, formerly DIL Limited, is an Indian biotechnology company built around one molecule: Vitamin D3. It demerged from a larger pharmaceutical business as a roughly Rs. 10 crore turnover company and has grown to around Rs. 400 crore, with FY22 consolidated revenue of Rs. 399 crores, up approximately 5.6% year-on-year (Q4 FY22 conca...

Read the full report →
RS rating: 82 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Fermenta Biotech Ltd. and 4,900+ companies.

Sign in
5-day free pass. No card required.